Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Dec 22, 2022 8:20pm
95 Views
Post# 35188435

RE:RE:RE:RE:RE:Dealing with impact of long waits for Medical Imaging

RE:RE:RE:RE:RE:Dealing with impact of long waits for Medical Imaging
G1945V wrote: You probably don't even know what a Cardiac MRI looks like if it hits you in the head. Have you ever been under one? And do you seriously believe the VMS+ does not fit in dealing with the devasting impact of long waits for medical imaging of the heart? No one suggested that the article deals with or that it zeros in directly with the VMS+. Do you ever use your common sense? 


G1945V

 



 
Now now, G lets be civil even if we disagree
 
Know the CT and MRI tech very well actually.
 
Then again-Your or my opinion matters little here G
It is the opinion of independent cardiologists(no not Ventripoint paid spokespeople) that matter, and ultimately sales that show demand for product
 
And as you know there was 15,000 in sales in the last 9 months with a 3 million loss
And zero sales in 2021 and again millions loss
 
WHAT did the Uk NICE expert panel(included a VPT paid consultant say about VPT?
 
"Two experts stated that, as VMS+ can be used with standard 2D echocardiography equipment, it requires less retraining of staff than current available 3D systems. However, the experts noted that VMS+ is more time consuming than fully automated echocardiograph systems, as it requires healthcare professionals to manually plot points on anatomical landmarks of the heart. Two experts felt that VMS+ would cost slightly more than current standard care due to the additional time it could take to complete an echocardiogram." 
 
•"Experts advised that more evidence is needed before VMS+ can be routinely used in the NHS. Experts disagreed about where VMS+ would provide the most benefit in the care pathway. One expert felt that VMS+ would provide little additional value than existing technologies."
Source:NICE Experts Comments
 
 
Source:Abstracted from UK NICE MIB Ventripoint

Hardly. A resounding endorsement, and miles away from promoters wild claims here
 
<< Previous
Bullboard Posts
Next >>